抗VEGF療法後のBRVOにおける網膜感受性

基本情報

NCT ID: NCT02527733
ステータス: 不明
試験のフェーズ: 第4相
試験タイプ: 介入
目標被験者数: 50
治験依頼者名: Fukushima Medical University

概要

The efficacy of anti-vascular endothelial growth factor (VEGF) therapy for branch retinal vein occlusion (BRVO) is shown, but its effect on retinal sensitivity is not fully investigated. The purpose of this study is to compare the changes in retinal sensitivity after ranibizumab therapy or combination therapy of ranibizumab and laser photocoagulation in eyes with BRVO.

対象疾患

Branch Retinal Vein Occlusion

介入

Ranibizumab(DRUG)

Ranibizumab and laser(DRUG)

依頼者（Sponsor）

Fukushima Medical University(OTHER)

実施施設 (1)

井草眼科医院

Fukushima, Fukushima, Japan(RECRUITING)